Abstract
Background. Gastrointestinal stromal tumors (GIST) frequently recur even after complete resection. The typical pattern of failure from GISTs is both local and distant with hepatic and peritoneal metastases being most common. Isolated abdominal-wall recurrence from GISTs has not been previously described.
Aim of the Study. To report an isolated abdominal-wound recurrence in the absence of widespread disease in a patient with GIST.
Methods. Case report of a GIST and isolated abdominal-wound recurrence after laparoscopic-assisted en bloc resection.
Results. Elderly male patient presented with an isolated abdominal wall incisional recurrence 18 mo after gastric resection and adjuvant imatinib mesylate therapy for a high-grade GIST.
Conclusions. Complete resection of gastrointestinal stromal tumors followed by imatinib therapy may alter the extent of recurrence.
Similar content being viewed by others
References
Pidhorecky I, Cheney RT, Kraybill WG, et al. Gastrointestinal Stromal tumors: current diagnosis, biologic behavior, and management. J Surg Onc 2000;7:705–712.
DeMatteo RP, Lewis JJ, Leung DL, et al. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg 2000;231:51–58.
Ng E-H, Pollock RE, Romsdahl MM. Prognostic implications of patterns of failure for gastrointestinal leiomyosarcomas. Cancer 1992;69:1334–1341.
Shabahang M, Livingstone AS. Cutaneous metastases from a gastrointestinal stromal tumor of the stomach: review of the literature. Dig Surg 2002;19:64–65.
Schwartz S, Spengler D. Needle tract recurrences after closed biopsy or sarcoma: Three cases and review of the literature. Ann Surg Onc 1997;4:228–236.
Shoup M, Brennan MF, Karpeh MS, et al. Port site metastasis after diagnostic laparoscopy for upper gastrointestinal tract malignancies: an uncommon entity. Ann Surg Onc 2002;9:632–636.
Cook TA, Dehn TCB. Port-site metastases in patients undergoing laparoscopy for gastrointestinal malignancy. BJS 1996;83:1419–1420.
Nduka CC, Monson JRT, Menzies-Gow N, et al. Abdominal wall metastases following laparoscopy. BJS 1994;81:648–652.
Hirota S, Isozaki K, Moriyama Y, et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 1998;279:577–580.
Ernst SI, Hubs AE, Przygodzki RM, et al. KIT mutation portends poor prognosis in gastrointestinal stromal/smooth muscle tumors. Lab Invest 1998;78:1633–1636.
Savage DG, Antman KH. Imatinib mesylate: a new oral targeted therapy. NEJM 2002;346:683–693.
Demitri GD, von Mehren M, Blanke CD, et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. NEJM 2002;347:472–480.
DeMatteo RP. The GIST of targeted therapy: a tumor (gastrointestinal stromal tumor), a mutated gene (c-kit), and a molecular inhibitor (STI571). Ann Surg Onc 2002;9:831–839.
Tuveson DA, Willis NA, Jacks T., et al. STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: biologic and clinical implications. Oncogene 2001;20:5054–5058.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cunningham, S.C., Shibata, D. & Volpe, C. Isolated abdominal wound metastasis from a gastrointestinal stromal tumor. Int J Gastrointest Canc 33, 129–132 (2003). https://doi.org/10.1385/IJGC:33:2-3:129
Issue Date:
DOI: https://doi.org/10.1385/IJGC:33:2-3:129